1. 1.1Staff of 50 workersInjection plant:-2 contiguous injection sectors-2 warehouses-50 machines including 14 double spindle-80% of the machines equipped with Cartesianrobots-Anthropomorphic robots for assembly at themachine level-Manufacture of bi-material moldAbout usLong-established company with young managers flexibles.We aim to create a workplace where people can grow and achieve optimal performance.Employees are involved in the way they can see how their individual contribution is linked to the majorstrategic objectives of the organisation.People is the real driving force of the company.Highly qualified and motivated multidisciplinary human resources team.Involved in searching for continuous improvement in management models and systems.

2. High precision injection and bi-injection mouldingservices and good quality / price productsQualityTechnical and human resourcesWe trust in the quality of our products.Integrated conception and developmentPersonalized serviceContinuous improvement of technological advances and performanceManufacturing cost returnReactivity and operating marginAnticipate market requirements.Committed european suppliers1.2 3. Consolidated balance sheetBalance Sheet2.1ASSETS 2.013 2.012Current assetsCash and equivalents 408.503,98 1.817.805,32 Accounts receivable 4.178.377,96 4.026.507,97 Inventories 1.230.159,23 651.676,77 Short-term investment 200.000,00 - Financial short-term investment 400.000,00 241.700,00 Total current assets 6.417.041,17 6.737.690,06 Noncurrent assetsProperty, plant and equipment 2.363.499,94 2.294.457,29 Long-term investment 500.000,00 - Financial long-term investment 307.919,09 296.641,85 Deferred asset tax 42.748,49 - Total noncurrent assets 3.214.167,52 2.591.099,14 Total assets 9.631.208,69 9.328.789,20 4. Liabilities and Shareholders' equity2.2Current liabilities 2013 2012Accounts payable 1.839.574,20 1.827.020,16 Current portions of long-term debt 86.000,04 - Total current liabilities 1.925.574,24 1.827.020,16 Noncurrent liabilitiesCurrent liabilitiesAccounts payable 1.839.574,20 1.827.020,16 Current portions of long-term debt 86.000,04 - Total current liabilities 1.925.574,24 1.827.020,16 Noncurrent liabilitiesLong-term debt 300.999,94 - Deferred liabilities tax 20.993,78 20.210,20 Total noncurrent liabilities 321.993,72 20.210,20 Shareholdes' equityEquity capital 7.334.655,25 7.434.401,72 Financial adjustment 48.985,48 47.157,12 Total sharholders' equity 7.383.640,73 7.481.558,84 Total liabilities and shareholders' equity 9.631.208,69 9.328.789,20 Long-term debt 300.999,94 - Deferred liabilities tax 20.993,78 20.210,20 Total noncurrent liabilities 321.993,72 20.210,20 Shareholdes' equityEquity capital 7.334.655,25 7.434.401,72 Financial adjustment 48.985,48 47.157,12 Total sharholders' equity 7.383.640,73 7.481.558,84 Total liabilities and shareholders' equity 9.631.208,69 9.328.789,20 5. Income Statement2.013 2.0122.3Revenues 10.489.048,72 12.122.647,13 Cost of sales - 6.823.207,25 - 8.077.669,45 Gross profit 3.665.841,47 4.044.977,68 Selling and administratives expenses - 3.583.779,78 - 3.190.008,84 Income from operations 82.061,69 854.968,84 Current liabilitiesAccounts payable 1.839.574,20 1.827.020,16 Current portions of long-term debt 86.000,04 - Total current liabilities 1.925.574,24 1.827.020,16 Noncurrent liabilitiesLong-term debt 300.999,94 - Deferred liabilities tax 20.993,78 20.210,20 Total noncurrent liabilities 321.993,72 20.210,20 Shareholdes' equityEquity capital 7.334.655,25 7.434.401,72 Financial adjustment 48.985,48 47.157,12 Total sharholders' equity 7.383.640,73 7.481.558,84 Total liabilities and shareholders' equity 9.631.208,69 9.328.789,20 Assets depreciation - 345.147,26 - 349.468,17 Miscellaneous 25.509,12 - Total other income - 237.576,45 505.500,67 Financial income 109.409,60 - 50.800,76 Financial expenses - 14.328,11 Financial results 95.081,49 - 50.800,76 Profit before tax - 142.494,96 454.699,91 Corporation tax 42.748,49 - 136.409,97 Net Income - 99.746,47 318.289,94 6. PriorityReduction of CostsAutomation at the injectionmachine level allow aconsiderable reduction of thecosts of large series Assembly of 4 components:-Interior-Exterior-Covers splints-Key/tapHigh production stationCost reductionMajor reliability3.1 7. 4.1Development and manufacture of conventional mouldsDevelopment and manufacture of bimaterial mouldsManaging and purchasing componentsProcess management and finished in pieceDevelopment and manufacture of automatisms of assembly 8. Molde en fabricacin bi-materia multicavidad 9. Clula ensamblaje carolina herrera 212 10. Bi-inyeccin en molde bi-materia 11. Sistema de comprobacin y medicin de calidad en mquina 12. IMPROVEMENTS- Automation at the machine level and Automation in line in order to minimize costs- Manufacture of bi-material multi-cavity mold- Injection of multicavity parts.4.2- Development of an innovative Surlyn injection system, in the process ofpatent, reducing injection cycle and improving the appearance of the piece- Adaptation of new Quality Systems testing machine- Development of a bi-injection system with high-density materials to replacemetal, which allows the encapsulation and rear chromed piece in stainlesssteel finishes, chrome, copper, shiny, matte and brushed- Measurement unit outflow valve- Adaptation of new machine quality systems in the test and measurementunit outflow valve- Development of an innovative Surlyn injection system, in the process of patent, reducingbetween 30 and 50% injection cycle, improving the appearance of the piece- Manufacture of bi-material multi-cavity mold- Development - Injection of a of bi-multicavity injection parts.system with high-density materials to replace metal, which allowsthe encapsulation and rear chromed piece in stainless steel finishes, chrome, copper, shiny,matte and brushed- Adaptation of new machine quality systems in the test and measurement unit outflow valve 13. Plsticos Transformados J.OLLER, S.AAvenida Riera, 18-08960 SANT JUST DESVERNSonia GaruzCustomer serviceT: +34 933712954+34 606886895Email: sgaruz@ptjosa.comWeb: www.ptjosa.com